Methods Development
Thermo Fisher Partners With South Korea’s Dr. Park CDMO To Deliver Advanced Bioprocessing Solutions For Large-Scale Cell And Gene Therapy Production
Advanced bioprocessing solutions from Thermo Fisher to support large-scale production and global access to cell and gene therapies Thermo Fisher Scientifi...
September 26, 2025 | News
Lonza and RION Partner to Scale Manufacturing of Exosome-Based Therapy PEP™
Lonza to support cGMP manufacturing of RION’s Purified Exosome Product™ (PEP™), a platelet-derived exosome-based drug candidate ...
September 24, 2025 | News
eXmoor Pharma and Siam Bioscience Partner to Build Southeast Asia’s Premier Cell and Gene Therapy Hub
eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Siam Bioscience, a leading biopharmaceutical company in A...
September 24, 2025 | News
ProBioGen to Operate GMP Manufacturing Hub at Berlin’s New Gene and Cell Therapy Centre
ProBioGen and the Berlin Institute of Health at Charité (BIH) announced that ProBioGen has been selected to operate the process...
September 17, 2025 | News
Single-Use Systems Are Rewiring Biopharma Manufacturing
Bioprocess, Unbottled Single-use systems (SUS) have become a transformative force in biopharmaceutical processing, offering an alternative to trad...
September 16, 2025 | Report
AGC Biologics Seattle Site Achieves New Heights in Manufacturing Excellence
Manufacturing excellence positions Seattle site as premier destination for mammalian and microbial biologic production in thriving Pacific Northwest life...
September 11, 2025 | News
KBI Biopharma and Infinimmune Partner to Advance Manufacturing of Lead Human-First Antibody IFX-101
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Infinimmune, Inc., a biotec...
September 09, 2025 | News
Thermo Fisher Completes $4B Acquisition of Solventum’s Purification & Filtration Business, Expanding Bioprocessing and Industrial Reach
Highly Complementary Technologies Strengthen Thermo Fisher’s Portfolio in Bioprocessing and Adjacent Markets Thermo Fisher Scientific Inc. , the wor...
September 02, 2025 | News
Antengene Reports Strong H1 2025 Results with Breakthrough Therapy Designation for ATG-022 and Robust Pipeline Progress
The Phase I/II CLINCH study of ATG-022 (CLDN18.2 antibody-drug conjugate) demonstrated promising results, showing robust clinical efficacy and a fav...
August 25, 2025 | Company results
WuXi XDC Delivers 62% Revenue Growth and Record Project Momentum in H1 2025
- Revenue increased by 62.2% YoY to RMB 2,701 million - Gross profit surged by 82.2% YoY to RMB 975 million, with i...
August 19, 2025 | Company results
WuXi Biologics Achieves Fully Automated Continuous Drug Substance Manufacturing at Pilot Scale with WuXiUP™ Platform
Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the ...
August 13, 2025 | News
ProBio Launches GMP AAV Manufacturing Services at New Jersey Facility to Accelerate Gene Therapy Development
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, announced the launch of its cGMP Adeno-...
August 12, 2025 | News
PolyActiva Launches U.S. Trial of Glaucoma Implant Following Australia Success
PA5108, a new chemical entity, is an investigational, biodegradable ocular micro implant, designed to deliver sustained intraocular pressure control for ...
August 08, 2025 | News
AGC Biologics Partners with Valneva to Advance Phase II Shigella Vaccine Supply from Heidelberg Site
AGC Biologics, your friendly CDMO expert, announced a development and manufacturing services agreement with specialty vaccine company Valneva SE ...
July 31, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
